116632-54-3Relevant articles and documents
Structure-based design of novel human toll-like receptor 8 agonists
Kokatla, Hari Prasad,Sil, Diptesh,Tanji, Hiromi,Ohto, Umeharu,Malladi, Subbalakshmi S.,Fox, Lauren M.,Shimizu, Toshiyoki,David, Sunil A.
, p. 719 - 723 (2014)
Toll-like receptor (TLR)-8 agonists activate adaptive immune responses by inducing robust production of T helper 1-polarizing cytokines, suggesting that TLR8-active compounds might be promising candidate vaccine adjuvants. Recently, a C2-butyl furo[2,3-c]
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part II
Das, Sanjib,Shelke, Dnyaneshwar E.,Harde, Rajendra L.,Avhad, Vijayshree B.,Khairatkar-Joshi, Neelima,Gullapalli, Srinivas,Gupta, Praveen K.,Gandhi, Maulik N.,Bhateja, Deepak K.,Bajpai, Malini,Joshi, Ashwini A.,Marathe, Megha Y.,Gudi, Girish S.,Jadhav, Satyawan B.,Mahat, Mahamad Yunnus A.,Thomas, Abraham
, p. 3238 - 3242 (2014/07/22)
We report the design and synthesis of novel pyrrolo[3,2-b]quinoline containing heteroarene ethers as PDE10A inhibitors with good to excellent potency, selectivity and metabolic stability. Further optimization of this primary series resulted in the identif